Chief, Cardiovascular Medicine

Peter Libby, M.D., is the Mallinckrodt Professor of Medicine at Harvard Medical School and the Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital, Boston, Massachusetts. Dr. Libby’s current major research focus is the role of inflammation in vascular diseases such as atherosclerosis.

He has received numerous awards and recognition for his research accomplishments including the Distinguished Scientist Award from the American College of Cardiology in 2006.

His areas of clinical expertise include general and preventive cardiology. An extensive author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published numerous research articles in medical journals including Circulation, The Journal of Clinical Investigation, The Proceedings of the National Academy of Sciences, The New England Journal of Medicine, and Nature. Dr. Libby has served as associate or consulting editor for Circulation, Arteriosclerosis and Thrombosis and The Journal of Clinical Investigation.

MD, PhD, FRCP, Fmed Sci

Sir Gordon Duff has accomplished extensive research focused in the fields of inflammation, cytokine biology, and genetics, and has authored more than 300 publications. He is recognized as one of the world’s leading experts on the role of genetics on the inflammatory process and chronic disease risk.

He and his colleagues were the first to report on varying inflammatory responses in relation to IL1 and TNFa genetic variations. He is accredited in General Medicine with specialist accreditation in Molecular Medicine and Clinical Rheumatology.

He chairs several UK national advisory bodies and currently heads the Biotechnology and Biological Sciences Research Council (BBSRC). He formerly was head of Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s equivalent of the FDA.

He is the recipient of several international prizes and honors and was previously Research Dean of the Sheffield Medical School, Research Director of the Faculty of Medicine and President of the International Cytokine Society.

Knighted in 2007 for his outstanding contributions to drug safety as Chairman of the UK Commission on Human Medicines, he was named in the 2014 Times Higher Education Review as one of the top 100 practicing scientists in the UK.


Florey Professor of Molecular Medicine

Principal, St Hilda’s College, University of Oxford, UKFormer Director of the Division of Genomic Medicine in the School of Medicine and Biomedical Sciences at the University of Sheffield, U.K.Former head of Medicines and Healthcare products Regulatory Agency (MHRA)
Professor of Genetics

Jose Ordovas, PhD, is Professor of Nutrition, Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and Professor of Genetics, Sackler School of Biomedical Sciences and the Director.

He is also senior scientist and Director of the Nutrition and Genomics Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), one of six human nutrition research centers in the United States supported by the Agricultural Research Service (ARS), the research arm of the United States Department of Agriculture (USDA).

His research focus includes molecular biology, nutrition and genetics; and lipoproteins and cardiovascular disease risk. An extensive author and lecturer, Dr. Ordovas is an internationally recognized expert in the intersection of genetics, cardiovascular disease, nutrition, and aging. He has over 400 publications, including original science, reviews, books and book chapters.

Professor of Genetics, Tufts University, Sackler School of Graduate Biomedical Sciences

Professor of Nutrition, Gerald J & Dorothy R Friedman School of Nutrition Sci. & PolicySenior Scientist & Director of the Nutrition & Genomics Lab, Jean Mayer USDA HumanNutrition Research Center on Aging, Tufts University Boston, MA
Professor of Medicine

Dr. Ginsburg is the founding director for Genomic Medicine in the Duke Institute for Genome Sciences & Policy and the founding executive director of the Center for Personalized and Precision Medicine in the Duke University Health System.  He is a professor of Medicine, Pathology, and Biomedical Engineering at Duke University.

He is an internationally recognized expert in genomics and personalized medicine with funding from NIH, DOD, Air Force, DARPA, the Gates Foundation, and industry.  Prior to Duke he was at Millennium Pharmaceuticals Inc where he was vice president of Molecular and Personalized Medicine and responsible for developing pharmacogenomic and biomarker strategies for therapeutics.

He serves as an expert panel member for Genome Canada, as a member of the Board of External Experts for the NHLBI, as Co-Chair of the Institute of Medicine’s Roundtable on Genome-Based Research to Human Health, as a member of the advisory council for the National Center for Accelerating Translational Science, as co-Chair of the Cures Acceleration Network, as an Advisor to the Pharmacogenetics Research Network, and as a member of the World Economics Forum’s Global Agenda Council on Personalized and Precision Health Care.

Founding Director for Genomic Medicine, Duke Institute for Genome Sciences & Policy

Founding Executive Director, Center for Personalized and Precision Medicine, Duke University Health SystemProfessor of Medicine, Pathology, and Biomedical Engineering, Duke University
Chair of Periodontics, UNC

Dr. Offenbacher received his bachelor’s degree in chemistry from Boston University, and his DDS and PhD in Biochemistry from Virginia Commonwealth University.

He completed a post doctorate fellowship in pharmacology, at Forsyth Institute, as well as a certificate in periodontology and oral medicine from Harvard.

He has received the Norton Ross  award for clinical research, the Gies Award and the Basic Research in Periodontal Disease Award from the International Association for Dental Research.

He is past president of the American Association of Dental Research and has conducted epidemiological and clinical research investigating the role of periodontal infections in systemic diseases.

Currently, his research laboratory is actively exploring the cellular and molecular mechanisms of periodontal disease pathogensis from an “omics” perspective.

WR Kenan Jr Distinguished Professor

Director, Center for Oral and Systemic Diseases
Chairman, Department of Periodontology, University of North CarolinaAmerican Dental Association Gold Medal Award for Excellence in Dental Researchmerican Dental Association’s Norton M. Ross Award for Excellence in Clinical Research